World Hepatitis Day 2026 and National Hepatitis Interventions

World Hepatitis Day 2026 and National Hepatitis Interventions

#GS-2 #GS-3 #Health #Governance & Social Justice #Government Policies & Interventions #Science & Technology #Biotechnology #National #International

Key takeaways

  • World Hepatitis Day is observed globally on 28th July, with the 2026 theme being "Hepatitis: Let's Break It Down".
  • India has 29 million chronic Hepatitis B cases and 5.5 million chronic Hepatitis C cases, ranking second globally in overall disease burden.
  • A major diagnosis gap exists in India, where only 2.4% of individuals infected with Hepatitis B are aware of their status.
  • The National Viral Hepatitis Control Programme (NVHCP) was launched in 2018 to eliminate viral hepatitis by 2030.
  • Modern Direct-Acting Antiviral drugs can cure over 95% of Hepatitis C patients within 12 to 24 weeks.

Why in News

  • The world observed World Hepatitis Day on 28th July to spread awareness about viral liver infections.
  • The official theme for 2026 is "Hepatitis: Let's Break It Down", focusing on removing social and financial barriers to medical care.

Key Facts About Hepatitis

  • Hepatitis refers to liver inflammation caused by viruses, alcohol, toxic drugs, or autoimmune diseases.
  • The name comes from the Greek word hepar, meaning liver, and itis, meaning inflammation.
  • Five distinct viral strains cause hepatitis, classified as types A, B, C, D, and E.
  • Types A and E spread through contaminated food or water due to poor sanitation.
  • Types B, C, and D spread through infected blood, bodily fluids, unsafe injections, or mother-to-child transmission during birth.
  • Types B and C cause over 90% of viral hepatitis deaths through cirrhosis, liver failure, and liver cancer.
  • Globally, viral hepatitis causes 1.34 million deaths and 2 million new infections every year.
  • Nearly 304 million people globally live with chronic Hepatitis B or C, and most remain unaware of their condition.
  • India has 29 million chronic Hepatitis B cases and 5.5 million chronic Hepatitis C cases.
  • India accounts for 10% to 15% of the global Hepatitis B carrier pool, ranking second among high-burden countries.
  • According to the 2021 HIV Sentinel Surveillance, Hepatitis B prevalence in India stood at 0.85%, while Hepatitis C was 0.29%.
  • Only 2.4% of Hepatitis B cases in India are diagnosed, leaving a massive testing gap.
  • India achieves 63% Hepatitis B birth-dose vaccine coverage, despite 93% coverage for the third vaccine dose in childhood.
  • Common symptoms include persistent fatigue, poor appetite, nausea, abdominal pain, dark urine, and jaundice.
  • Pregnant women infected with Hepatitis E face a significantly higher risk of acute liver failure.
  • Hepatitis D is a defective virus that infects only individuals who already carry Hepatitis B.
  • The World Health Organization (WHO) aims for a 90% reduction in new infections and a 65% reduction in deaths by 2030.

Modes of Transmission, Prevention, and Management

  • Hepatitis A and E spread via the fecal-oral route through contaminated food or water.
  • Prevention for Hepatitis A and E relies on clean drinking water, good hygiene, sanitation, and available vaccines.
  • Treatment for Hepatitis A and E is supportive, focusing on hydration and nutrition since the infection resolves on its own.
  • Hepatitis B transmits through infected blood, bodily fluids, and mother-to-child transmission during birth.
  • Prevention for Hepatitis B involves giving newborns a birth dose vaccine within 24 hours, followed by doses at 6, 10, and 14 weeks.
  • Chronic Hepatitis B is managed using daily antiviral medications based on clinical guidelines.
  • Hepatitis C spreads through contact with infected blood, unsterile medical equipment, or shared needles.
  • No vaccine exists for Hepatitis C, but safe blood transfusion practices and harm reduction programs help prevent its spread.
  • Direct-Acting Antiviral drugs cure over 95% of Hepatitis C cases within 12 to 24 weeks.
  • Hepatitis D spreads through infected blood and only affects people already infected with Hepatitis B.
  • Vaccinating individuals against Hepatitis B automatically protects them from Hepatitis D infection.

National Viral Hepatitis Control Programme

  • The Indian government launched the National Viral Hepatitis Control Programme (NVHCP) in 2018.
  • The programme aims to eliminate viral hepatitis as a public health threat by 2030, supporting Sustainable Development Goal 3.3.
  • It covers all five viral strains (A, B, C, D, and E) through preventive, diagnostic, and treatment services.
  • The Integrated Disease Surveillance Programme monitors outbreak-prone Hepatitis A and E cases across the country.
  • The government provides free diagnostic testing and essential medications for chronic Hepatitis B and C.
  • Healthcare providers use the digital NVHCP Management Information System portal for paperless patient registration and monitoring.

Supporting National Health Programmes

  • The Reproductive, Maternal, Newborn, Child, Adolescent Health and Nutrition (RMNCH+A) program conducts universal screening of pregnant women for Hepatitis B.
  • The Universal Immunisation Programme (UIP) provides the birth-dose vaccine to all newborns within 24 hours.
  • Newborns of Hepatitis B positive mothers receive both the vaccine and Hepatitis B Immunoglobulin at birth.
  • The National AIDS Control Programme (NACP) screens high-risk populations and vaccinates eligible healthcare workers.
  • The National Tuberculosis Elimination Programme (NTEP) shares its molecular testing machines to diagnose viral hepatitis.
  • Patients can call the toll-free helpline 1800-11-6666 to get information on hepatitis prevention and nearby treatment centers.
  • Blood banks screen donors and link individuals testing positive for Hepatitis B or C to treatment facilities.

Way Forward

  • India needs sustained financial funding to strengthen primary healthcare facilities for liver care.
  • Health authorities must expand screening campaigns to identify millions of undiagnosed carriers early.
  • Hospitals must ensure that every newborn receives the Hepatitis B birth dose within the first 24 hours.
  • Public health campaigns must dispel social stigma and educate communities about safe injection practices.